Mission: We help to improve the health of humankind.
A group of our CA employees recently used their volunteer time off benefit to volunteer at Feeding San Diego where they sorted 3,500 pounds of bananas!
Congratulations to our newest Cultural Champions! Thank you for embodying our cultural values in your daily activities. We appreciate you and are proud to have you on our team!
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our client’s needs. Learn more: www.AjiBio-Pharma.com
Meet our dedicated leadership team, with a passion and commitment to exemplifying the Ajinomoto Bio-Pharma Services values, by clicking here
President and Chief Executive Officer
David Enloe has over 20 years of executive management experience in biotechnology, clinical drug development and GMP manufacturing. As President and CEO, he is responsible for overseeing all aspects of the Ajinomoto Bio-Pharma Services CDMO business. Mr. Enloe serves on the boards of both Ajinomoto Bio-Pharma Services legacy organizations, Ajinomoto Althea and Ajinomoto OmniChem. He also serves as a Corporate Executive Officer of Ajinomoto Co., Inc.
Vice President of Finance and Chief Financial Officer, US
Mr. Logan has over 25 years of diverse finance and accounting leadership and executive management experience. At Ajinomoto Bio-Pharma Services, he is responsible for the all corporate finance & accounting functions, investment strategy, and overseeing administrative, IT and legal operations for the US operations.
Kristin DeFife, Ph.D.
Vice President and Head of US Operations
Dr. DeFife has 20 years of successful leadership and biologics development and manufacturing experience in the biotechnology industry. At Ajinomoto Bio-Pharma Services, she is responsible for the US operations and driving performance measures at the San Diego facilities.
Vice President of Drug Product Manufacturing, US
Bert Barbosa joined the leadership team in May 2018, bringing with him over 35 years of bio-pharmaceutical production, quality assurance and compliance leadership and management experience. At Ajinomoto Bio-Pharma Services he is responsible for overseeing and managing the drug product manufacturing operations, ADC/Cytotoxic product development activities and associated personnel.
Vice President of Compliance, US
Darwin Richardson joined the leadership team in June 2018, bringing over 25 years of leadership and executive management in quality operation, regulatory compliance and manufacturing operations in bio-pharmaceutical manufacturing. At Ajinomoto Bio-Pharma Services, he is responsible for ensuring compliance oversight of Quality operations and Environmental Health and Safety for US Operations.
Althea Technologies was founded by Magda Marquet, Ph.D. and Francois Ferre, Ph.D. in 1998 and began by developing plasmid kits and gene quantification assays. In 2000, it further expanded into microbial biologics manufacturing. In 2003, Althea began offering fill and finish manufacturing to meet the growing demands of its clients. Campus enhancements and scale up capabilities permitted Althea to sign its first commercial client in 2008. Althea acquired WindRose Analytica in 2009 and became a fully integrated CMO offering our clients Analytical Development Services.
Althea enhanced its service offering by acquiring Altus Pharmaceuticals’ Crystalomics® protein crystallization technology in 2010.Althea had a successful PAI in 2011, which validated the company as a large scale commercial manufacturing facility.
In 2013, Althea Technologies Inc. was acquired by global Japanese manufacturer, Ajinomoto Co. which provided access to the new proprietary Corynex Protein Expression System.
In 2018, Ajinomoto Althea and OmniChem integrated their services offerings and began doing business as Ajinomoto Bio-Pharma Services.
Ajinomoto Bio Pharma-Services has partnered with many different clients ranging from small to large biopharmaceutical companies, government agencies, and universities, on both a local and international scale. They have worked on thousands of projects varying from the production of recombinant proteins, plasmid DNAs, vaccines, antibody fragments, to the fill and finish of injectable peptides, monoclonal antibodies, oligonucleotides, and small molecules.
I have been working at Ajinomoto Bio-Pharma Services full-time (More than a year)
From day one the company makes you feel comfortable and part of the team. The benefits are great, low cost medical with option for every phase of life, good matching 401K and much more. The HR group works hard to ensure people are treated fairly and to make the work experience the best as it can be. The people at the company are smart and work hard, they make working there a pleasure. I truly belief that from the VPs on down they care about the success of people.
Planning could be better, most times things get done with heroic effort of the people. Equipment can be updated as well, but this is typical of a CMO.
Advice to Management
Offer more sick time, we work closely together and 5 days is not enough working in this industry.
I applied online. The process took 2 weeks. I interviewed at Ajinomoto Bio-Pharma Services in April 2018.
The interview process was great. Every employee at Althea was very friendly and helpful throughout the process. The hiring manger organized meetings with three different managers/supervisors (each took about 30 mins - 1 hour) for the interview. Took about a week to hear back and another week to receive an offer.
Social Responsibility Pledge
Formal programs or foundation to give back to communities
Pay Equality Pledge
Committed to paying equitably for equal work & experience